PMID- 30989700 OWN - NLM STAT- MEDLINE DCOM- 20191217 LR - 20210109 IS - 1932-8737 (Electronic) IS - 0160-9289 (Print) IS - 0160-9289 (Linking) VI - 42 IP - 6 DP - 2019 Jun TI - Long-term outcomes in Japanese nonagenarians undergoing transcatheter aortic valve implantation: A multi-center analysis. PG - 605-611 LID - 10.1002/clc.23183 [doi] AB - BACKGROUND AND HYPOTHESIS: Japan is an aging society, and the number of nonagenarians with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI) is increasing, but their outcomes have not been determined fully. METHODS: We prospectively enrolled 767 consecutive patients who underwent TAVI in three Japanese institutions. Clinical characteristics and outcomes of nonagenarians (n = 94) were evaluated and compared with those of patients aged <90 years (n = 673). RESULTS: Prevalence of New York Heart Association (NYHA) class III/IV was not different between the two groups. Preoperative risk scores were significantly higher in nonagenarians compared with those in non-nonagenarians, whereas the Clinical Frailty Scale was not different. Thirty-day mortality tended to be higher (P = .06) and major vascular complication was significantly higher in nonagenarians than in non-nonagenarians (P < .05), but 3-year mortality was equivalent between the two groups. Even after adjustment for covariates, female sex (hazard ratio, 0.41; 95% confidence interval: 0.25-0.67), body mass index (0.87, 0.80-0.94), and NYHA class III/IV (1.84, 1.06-3.29) were associated with all-cause mortality. Age >/= 90 years was not associated with all-cause mortality. CONCLUSIONS: TAVI could be undertaken safely and effectively in nonagenarians, who had acceptable long-term results compared with those for younger patients, although careful attention should be paid to major vascular complication. CI - (c) 2019 The Authors. Clinical Cardiology published by Wiley Periodicals, Inc. FAU - Yokoyama, Hiroaki AU - Yokoyama H AUID- ORCID: 0000-0001-6452-6413 AD - Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan. AD - Department of Cardiology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan. FAU - Tobaru, Tetsuya AU - Tobaru T AD - Department of Cardiology, Kawasaki Saiwai Hospital, Kawasaki, Japan. FAU - Muto, Yuki AU - Muto Y AD - Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan. FAU - Hagiya, Kenichi AU - Hagiya K AD - Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan. FAU - Higuchi, Ryosuke AU - Higuchi R AD - Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan. FAU - Saji, Mike AU - Saji M AD - Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan. FAU - Takamisawa, Itaru AU - Takamisawa I AD - Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan. FAU - Shimizu, Jun AU - Shimizu J AD - Department of Anesthesiology, Sakakibara Heart Institute, Tokyo, Japan. FAU - Takanashi, Shuichiro AU - Takanashi S AD - Department of Cardiovascular Surgery, Sakakibara Heart Institute, Tokyo, Japan. FAU - Takayama, Morimasa AU - Takayama M AD - Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan. FAU - Tomita, Hirofumi AU - Tomita H AD - Department of Cardiology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan. FAU - Tamura, Harutoshi AU - Tamura H AD - Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan. FAU - Doi, Shinichiro AU - Doi S AD - Department of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan. FAU - Okazaki, Shinya AU - Okazaki S AD - Department of Cardiovascular Medicine, Juntendo University School of Medicine, Tokyo, Japan. FAU - Isobe, Mitsuaki AU - Isobe M AD - Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan. LA - eng PT - Journal Article PT - Multicenter Study DEP - 20190423 PL - United States TA - Clin Cardiol JT - Clinical cardiology JID - 7903272 SB - IM MH - Age Factors MH - Aged, 80 and over MH - Aortic Valve/*surgery MH - Aortic Valve Stenosis/mortality/*surgery MH - Female MH - Follow-Up Studies MH - Humans MH - Incidence MH - Japan/epidemiology MH - Male MH - Postoperative Complications/*epidemiology MH - Prospective Studies MH - Risk Factors MH - Severity of Illness Index MH - Survival Rate/trends MH - Time Factors MH - Transcatheter Aortic Valve Replacement/*methods MH - Treatment Outcome PMC - PMC6553359 OTO - NOTNLM OT - TAVI OT - long-term outcome OT - nonagenarians COIS- The authors declare no potential conflict of interests. EDAT- 2019/04/17 06:00 MHDA- 2019/12/18 06:00 PMCR- 2019/04/23 CRDT- 2019/04/17 06:00 PHST- 2019/03/11 00:00 [received] PHST- 2019/04/13 00:00 [accepted] PHST- 2019/04/17 06:00 [pubmed] PHST- 2019/12/18 06:00 [medline] PHST- 2019/04/17 06:00 [entrez] PHST- 2019/04/23 00:00 [pmc-release] AID - CLC23183 [pii] AID - 10.1002/clc.23183 [doi] PST - ppublish SO - Clin Cardiol. 2019 Jun;42(6):605-611. doi: 10.1002/clc.23183. Epub 2019 Apr 23.